PaxMedica Inc

PaxMedica, Inc. is an early clinical stage biopharmaceutical company. It focuses on the development of anti-purinergic therapies for the treatment of neurodevelopmental disorders, including autism spectrum disorder and Fragile X syndrome tremor-ataxia. The company was founded in April 5, 2018 and is headquartered in Woodcliff Lake, NJ.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.

Additional Capital Will Help Fund Development of PAX-101

PaxMedica, Inc. Secures $3.2 Million Growth Capital From Lind Partners

Grom Social Enterprises

Silvergate Capital Corp

Retail investors have taken a particular interest in potential short-squeeze stocks ever since the onset of the coronavirus pandemic. At that time, meme stock favorite GameStop (NYSE: GME ) squeezed to unimaginable levels, wreaking havoc on Wall Street investors with short positions.

Short Squeeze Stocks: 5 Stocks Wall Street Really DOESN'T Want to Win

Carvana

Sitio Royalties Corp

The macroeconomic climate in 2022 and 2023 has had a negative impact on many equity investments. Fears of a possible recession and a gloomy attitude among investors have affected companies in precarious financial situations.

Top 5 most-shorted stocks as of January 2023

Presentation on Thursday, January 26th, 2023 at 1:30 PM EST

PaxMedica to Present at the Jan 26th Virtual Investor Summit Microcap Event

Gossamer Bio Inc

Summit Therapeutics

Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Short Squeeze Penny Stocks To Watch Before 2023

Update Offers More Comprehensive Understanding of PaxMedica's Focus, Process and Progress

PaxMedica, Inc. Launches Updated Corporate Website at PaxMedica.com

Blue Apron

Bed Bath & Beyond

NeuroBo Pharmaceuticals Inc

Opendoor

Workhorse Group

Penny stocks to watch with higher short interest right now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 7 Short Squeeze Stocks To Watch Now

Best Penny Stocks To Buy? 4 Short Squeeze Stocks To Watch Now

TARRYTOWN, NY, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced it will be presenting at the Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City.

PaxMedica to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Abeona Therapeutics

Getty Images Holdings Inc

Hour Loop

SurgePays

We're checking in on the top short squeeze stocks to watch this week as traders continue to have an interest in this part of the market! Short squeeze stocks are often subject to volatility with massive gains.

PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week

Ginkgo Bioworks Holdings

Kinross Gold

Check out these reasons to buy penny stocks in 2022 The post Are Penny Stocks too Risky to Invest In? 3 Reasons to Consider  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are Penny Stocks too Risky to Invest In? 3 Reasons to Consider

AMC Preferred Equity Unit

RLX Technology

Understand these tips for finding penny stocks to buy The post Thinking Of Buying Penny Stocks? Here's What to Look For appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Thinking Of Buying Penny Stocks? Here's What to Look For

PaxMedica (NASDAQ: PXMD ) stock is taking off on Friday after the biopharmaceutical company entered into an investment agreement with Lincoln Park Capital Fund. According to a press release, this covers a purchase agreement and registration rights agreement for up to $20 million.

Why Is PaxMedica (PXMD) Stock Up 51% Today?

-Agreement Provides Flexible Funding on Path to NDA Submission for PAX-101-

PaxMedica, Inc. Enters Into Committed Equity Investment Agreement for up to $20 Million With Lincoln Park Capital

-PXMD Strengthened Executive Team and Board of Directors With Recent Appointments After IPO in August 2022-

PaxMedica, Inc. Provides Business Update and Reports Third Quarter 2022 Financial Results

Final Study Results are Expected in First Half of 2023

PaxMedica Initiates Clinical Program to Advance PAX-101 Towards FDA Submission

PaxMedica (NASDAQ: PXMD ) stock could be preparing for a short squeeze with recent signs showing potential for it to surge in price. Let's start off with the basics, which include the company completing its initial public offering ( IPO ) near the end of August.

A Major Squeeze Is Brewing in PaxMedica (PXMD) Stock

Dr. Schwabe brings 30+ years of Clinical Experience in the Pharmaceutical Industry

PaxMedica Appoints Stefan Schwabe MD, PhD as Chief Medical Officer

Innovative Eyewear Inc

SaverOne 2014 Ltd

Vallon Pharmaceuticals

Low float penny stocks to watch this week. The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 4 Low Float Stocks To Watch This Week

Founder of several public life sciences companies including Questcor, Osteologix and Indevus, Casamento will serve as an Independent Director

PaxMedica Appoints Specialty Pharma Industry Leader Charles J. Casamento to Its Board of Directors

MicroVision

Senseonics Holdings

SelectQuote

Hot penny stocks to buy for under $5 but are they worth the risk? The post Penny Stocks To Buy: 4 Stocks Under $5 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Buy: 4 Stocks Under $5 To Watch This Week

-PXMD Strengthened Executive Team with Recent Appointment of Stephen D. Sheldon As Chief Financial Officer-

PaxMedica, Inc. Provides Corporate Update After IPO

New Age Beverages

United Maritime Corp

Which penny stocks are on your watchlist today? The post Hot Penny Stocks to Buy After the Long Weekend?

Hot Penny Stocks to Buy After the Long Weekend? 3 to Watch

Chembio Diagnostics

InMed Pharmaceuticals

Here's what you need to know about trading penny stocks on September 2nd The post Trending Penny Stocks For Your September Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trending Penny Stocks For Your September Watchlist

Eagle Bulk Shipping

Golden Ocean Group

Kohl's

ZIM Integrated Shipping Services

Source: Darryl Brooks / Shutterstock.com Shipping stocks are sinking on Friday as reports come in that U.S. ports are still having trouble following turbulence during the pandemic. Shipping companies have been dealing with problems ever since the pandemic started.

Why Are Shipping Stocks Down Today?

News for PaxMedica Inc Stock (PXMD)